ARISTOCRAT'S US EXPANSION DELIVERS BUMPER PROFIT

ARISTOCRAT'S US EXPANSION DELIVERS BUMPER PROFIT

POKER machine maker Aristocrat has made the most of its expansion into the US lifting its annual net profit by 41.3 per cent to $495.1 million.

The US expansion included the acquisition of Seattle-based social gaming company Big Fish Games for $A1.4 billion and Aristrocrat says it expects the solid growth to continue through until the end of FY18.

CEO Trevor Croker says Aristocrat did face increased competition but managed to deliver another strong result.

"Industry-leading content, hardware and technology, coupled with effective execution focused on our highest-value opportunities, once again underpinned our performance," Croker says.

"Going forward, Aristocrat will continue to target high-quality growth, with the benefit of our established performance momentum, broadening capabilities, strong balance sheet and growing recurring revenue base."

Aristocrat says the acquisition of Big Fish Games will help drive revenue growth even further. Big Fish is a global publisher of free-to-play games that focus on specific segments, including social casino, social gaming and premium paid games and has well-known brands such as Gummy Drop! and Fairway Solitaire.

Big Fish will operate as a stand-alone business alongside Aristocrat's other social gaming operations, Product Madness and Plarium.

"The strategic and financial benefits from the acquisition are highly compelling," Croker says.

"The acquisition of Big Fish will immediately provide scale across our entire digital platform, following the recent acquisition of Plarium, which expanded our digital business into the fast-growing social gaming market."

Big Fish has about 700 employees and five studios in Seattle and Oakland in the US.

The solid results follow on from Aristrocrat's half year profit rise of 57 per cent and revenue lift of 22 percent, which was also led by growth in the United States.

The company, however, still faces the uncertainty of a legal case involving one of its machines.

The landmark pro-bono legal test which was undertaken by Maurice Blackburn lawyers to highlight the "deceptive and misleading behaviour" of pokies manufacturers and venues will begin in the Federal Court with Aristocrat and James Packer's Crown Resorts as defendants in the case.

The first-of-its-kind case will focus on the design of poker machines which allegedly contribute to players being deliberately deceived on their prospects of winning, in particular the design of the "Dolphin Treasure" machine. The potential financial ramifications of this lawsuit on Aristocrat are unclear.

It was new CEO and MD Croker's first big test since he replaced Jamie O'Dell in early 2017, with Aristocrat recording its 10th consecutive period of growth with its half year results in March.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Employee resilience is key to business resilience
Partner Content
Employee mental health and wellbeing is top of mind for Australian businesses, and or...
Aon
Advertisement

Related Stories

Daniel Andrews calls for "ring of steel" around Sydney as Victoria records 14 new cases

Daniel Andrews calls for "ring of steel" around Sydney as Victoria records 14 new cases

After Gladys Berejiklian today declared the COVID-19 situation in...

NSW outbreak a "national emergency" as state records 136 locally acquired cases

NSW outbreak a "national emergency" as state records 136 locally acquired cases

Both NSW premier Gladys Berejiklian and Chief Health Officer Dr K...

NZ to suspend Australian quarantine-free travel for eight weeks

NZ to suspend Australian quarantine-free travel for eight weeks

The worsening COVID-19 situation in NSW with transmission into ot...

TGA grants provisional approval of Pfizer COVID-19 jab for those aged as young as 12

TGA grants provisional approval of Pfizer COVID-19 jab for those aged as young as 12

The Therapeutic Goods Administration (TGA) has provisionally appr...